Skip to content

Menu

HomeAboutServices
Sean P. Wajert of Shook, Hardy & Bacon LLP logo
Contact
Subscribe
Search
Close
Published by Sean P. Wajert

Mass Tort Defense

Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation

advertising

Subscribe to advertising

Second Circuit Rejects Claims Over Scientific Literature

By Sean Wajert on July 9, 2013
Posted in Articles, Drug and Device

The Second Circuit recently held that scientific opinions voiced during debate of unsettled questions generally cannot support false advertising or de…
Continue Reading Second Circuit Rejects Claims Over Scientific Literature

Consumer Fraud Claim on “All Natural” Beverage Rejected

By Sean Wajert on May 23, 2012
Posted in Articles, Class Action, Consumer Fraud, Consumer Products, Food and Beverage

One trend we are keeping an eye on here at MassTortDefense is plaintiffs’ aggressive and excessive use of consumer fraud act claims, micro-analyzing e…
Continue Reading Consumer Fraud Claim on “All Natural” Beverage Rejected

State Committee Misses Opportunity for Class Action Reform

By Sean Wajert on May 14, 2012
Posted in Articles, Class Action

Readers of MassTortDefense recognize that one of the most challenging jurisdictions for potential class actions defendants is California, given the su…
Continue Reading State Committee Misses Opportunity for Class Action Reform

House Hearing on Food Marketing to Kids — Seller Beware

By Sean Wajert on October 21, 2011
Posted in Articles, Food and Beverage

Two subcommittees of the House Energy and Commerce Committee, the Subcommittee on Commerce, Manufacturing, and Trade and the Subcommittee on Health, h…
Continue Reading House Hearing on Food Marketing to Kids — Seller Beware

FDA Proposes Regs on Direct-to-Consumer Prescription Drug Ads

By Sean Wajert on April 12, 2010
Posted in Articles, Drug and Device

The Food and Drug Administration has proposed to amend its regulations concerning direct-to- consumer (DTC) advertisements of prescription drugs. Spec…
Continue Reading FDA Proposes Regs on Direct-to-Consumer Prescription Drug Ads

Device Group Comments on FDA Draft Guidance on Risk Information

By Sean Wajert on September 3, 2009
Posted in Articles, Drug and Device

Readers of MassTortDefense know how FDA regulatory treatment of advertising and promotion can impact product liability litigation involving drugs and …
Continue Reading Device Group Comments on FDA Draft Guidance on Risk Information

Senate Panel Holds Hearing on DTC Advertising of Medical Devices

By Sean Wajert on September 25, 2008
Posted in Articles, Drug and Device

The U.S. Senate Special Committee on Aging held a hearing last week to examine issues related to direct-to-consumer (DTC) advertising for medical devi…
Continue Reading Senate Panel Holds Hearing on DTC Advertising of Medical Devices

Published by
Sean P. Wajert
Phone: 215.278.2430
Fax: 215.278.2594
Email: swajert@shb.com
Add this blog to your RSS feeds Connect with me on LinkedIn Follow me on Twitter
Privacy PolicyDisclaimer

About My Practice

Mass Tort Defense Lawyer & Attorney Sean P. Wajert of Shook, Hardy & Bacon LLP, offering services relating to mass torts, product liability, class actions, medical monitoring, pharmaceutical litigation, consumer fraud act defense, complex litigation.

Read More...

Categories

Archives

Copyright © 2023, Sean P. Wajert of Shook, Hardy & Bacon LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo